Mucosal surfaces are promising routes for vaccination. Among mucosa, airway mucosa
provides the opportunity to develop non-invasive approaches for vaccine delivery. In the …

With the discovery of tumor-associated antigens such as ErbB2, vaccination is considered
as a promising strategy to prevent the development of cancer or treat the existing disease …

Liposomes have emerged as interesting vehicles in cancer vaccination strategies as their
composition enables the inclusion of both hydrophilic and hydrophobic antigens and …

Specific active immunotherapy employing crude or purified tumour cell extracts containing
tumour-associated antigens (TAA) is of interest as a therapeutic modality for cancer …

Importance of the field: Among the particulate systems that have been envisaged in vaccine
delivery, liposomes are very attractive. These phospholipid vesicles can indeed deliver a …

Mucosal surfaces contain specialized dendritic cells (DCs) that are able to recognize foreign
pathogens and mount protective immunity. We previously demonstrated that intranasal …

Liposomes are safe, biocompatible, and biodegradable spherical nanosized vesicles
produced from cholesterol and phospholipids. Recently, liposomes have been widely …

Purpose Personalized peptide-based cancer vaccines will be composed of multiple patient
specific synthetic long peptides (SLPs) which may have various physicochemical properties …

Cancer immunotherapy is one of the commonly used methods in the treatment of cancer.
The aim of this approach is to strengthen or restore immune function for effective diagnosis …

Liposomes as a drug delivery system are well established with around 15 products in
clinical use. However, liposomes also offer a range of advantages for the delivery of …